International AIDS Vaccine Initiative

Patent Applications and Registrations

Patent applications and USPTO patent grants for International AIDS Vaccine Initiative.The latest application filed is for "multispecific anti-hiv antibodies".

Company Profile

38.81.51

International AIDS Vaccine Initiative - New York NY US
International AIDS Vaccine Initiative -

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Multispecific Anti-HIV Antibodies App 20220227845 - Li; Yuxing ; et al.	2022-07-21
Methods of treating HIV-1 infection utilizing broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibodies Grant 11,319,362 - Chan-Hui , et al. May 3, 2	2022-05-03
Broadly neutralizing antibody and uses thereof Grant RE49,037 - Burton , et al. April 19, 2	2022-04-19
Engineered outer domain (eOD) of HIV GP120, mutants and use thereof Grant 11,248,027 - Schief , et al. February 15, 2	2022-02-15
Immunogenic trimers Grant 11,203,617 - Steichen , et al. December 21, 2	2021-12-21
Ferritin Nanoparticle Displaying An Hiv Trimer App 20210363194 - Tokatlian; Talar ; et al.	2021-11-25
Recombinant Hiv Env Polypeptides And Their Use App 20210363195 - STEICHEN; Jon M. ; et al.	2021-11-25
Anti-hiv Antibodies App 20210355197 - LANDAIS; Elise ; et al.	2021-11-18
Multispecific antibodies targeting human immunodeficiency virus and methods of using the same Grant 11,149,082 - Guenaga , et al. October 19, 2	2021-10-19
Enginerred Antibodies To Hiv Env App 20210292396 - SOK; Devin ; et al.	2021-09-23
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Activity App 20210040186 - Chan-Hui; Po-Ying ; et al.	2021-02-11
Recombinant Viral Vectors App 20210040158 - Parks; Christopher L. ; et al.	2021-02-11
Transgenic VERO-CD4/CCR5 cell line Grant 10,894,080 - Parks , et al. January 19, 2	2021-01-19
N-glycan deleted HIV-1 envelope glycoprotein trimers Grant 10,870,683 - Dubrovskaya , et al. December 22, 2	2020-12-22
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 10,865,234 - Chan-Hui , et al. December 15, 2	2020-12-15
Recombinant viral vectors Grant 10,844,095 - Parks , et al. November 24, 2	2020-11-24
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Grant 10,836,811 - Chan-Hui , et al. November 17, 2	2020-11-17
Optimized HIV envelope gene and expression thereof Grant 10,792,357 - Parks , et al. October 6, 2	2020-10-06
Novel Vesicular Stomatitis Virus And Virus Rescue System App 20200172932 - Parks; Christopher L. ; et al.	2020-06-04
Rapid Elicitation Of Broadly Neutralizing Antibodies To Hiv Env App 20200165324A1 -	2020-05-28
Vesicular stomatitis virus and virus rescue system Grant 10,544,430 - Parks , et al. Ja	2020-01-28
Broadly Neutralizing Human Immunodeficiency Virus Type 1 (hiv-1) Gp120-specific Monoclonal Antibody App 20200024330 - Chan-Hui; Po-Ying ; et al.	2020-01-23
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Acti App 20190338017 - Chan-Hui; Po-Ying ; et al.	2019-11-07
Engineered outer domain (EOD) of HIV GP120 and mutants thereof Grant 10,421,789 - Huang , et al. Sept	2019-09-24
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 10,407,493 - Chan-Hui , et al. Sept	2019-09-10
Transgenic Vero-cd4/ccr5 Cell Line App 20190216915 - Parks; Christopher L. ; et al.	2019-07-18
Optimized Hiv Envelope Gene And Expression Thereof App 20190201522 - Parks; Christopher L. ; et al.	2019-07-04
Engineered Outer Domain (eod) Of Hiv Gp120 And Mutants Thereof App 20190194262 - Huang; Po-Ssu ; et al.	2019-06-27
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Acti App 20190169273 - Chan-Hui; Po-Ying ; et al.	2019-06-06
Recombinant Viral Vectors App 20190153043 - Parks; Christopher L. ; et al.	2019-05-23
N-glycan Deleted Hiv-1 Envelope Glycoprotein Trimers App 20190135872 - Dubrovskaya; Viktoriya ; et al.	2019-05-09
Transgenic Vero-CD4/CCR5 cell line Grant 10,279,027 - Parks , et al.	2019-05-07
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 10,239,934 - Chan-Hui , et al.	2019-03-26
Immunogenic Trimers App 20190085033 - Steichen; Jon ; et al.	2019-03-21
Optimized HIV envelope gene and expression thereof Grant 10,220,087 - Parks , et al.	2019-03-05
Engineered outer domain (eOD) of HIV gp120 and mutants thereof Grant 10,221,217 - Huang , et al.	2019-03-05
Recombinant viral vectors Grant 10,202,424 - Parks , et al. Feb	2019-02-12
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Activity App 20190031742 - Chan-Hui; Po-Ying ; et al.	2019-01-31
Soluble HIV-1 envelope glycoprotein trimers Grant 10,174,292 - Dubrovskaya , et al. J	2019-01-08
Broadly neutralizing antibody and uses thereof Grant 10,093,720 - Burton , et al. October 9, 2	2018-10-09
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Grant 10,087,239 - Chan-Hui , et al. October 2, 2	2018-10-02
Neutralization-resistant CDV mutants and viral vectors Grant 10,081,796 - Zhang , et al. September 25, 2	2018-09-25
Soluble HIV-1 envelope glycoprotein trimers Grant 10,058,604 - Wyatt , et al. August 28, 2	2018-08-28
Engineered Outer Domain (eod) Of Hiv Gp120, Mutants And Use Thereof App 20180194809 - Schief; William ; et al.	2018-07-12
Methods to improve vector expression and genetic stability Grant 9,944,935 - Parks , et al. April 17, 2	2018-04-17
Soluble HIV-1 envelope glycoprotein trimers Grant 9,931,394 - Sharma , et al. April 3, 2	2018-04-03
Replication-competent VSV-HIV Env vaccines Grant 9,925,258 - Parks , et al. March 27, 2	2018-03-27
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 9,920,111 - Chan-Hui , et al. March 20, 2	2018-03-20
Broadly Neutralizing Human Immunodeficiency Virus Type 1 (hiv-1) Gp120-specific Monoclonal Antibody App 20180057570 - Chan-Hui; Po-Ying ; et al.	2018-03-01
Recombinant Viral Vectors App 20170327544 - PARKS; Christopher L. ; et al.	2017-11-16
Recombinant viral vectors Grant 9,802,986 - Parks , et al. October 31, 2	2017-10-31
HIV-1 broadly neutralizing antibodies Grant 9,796,774 - Mascola , et al. October 24, 2	2017-10-24
Transgenic Vero-cd4/ccr5 Cell Line App 20170266272 - Parks; Christopher L. ; et al.	2017-09-21
HIV-1 envelope glycoprotein Grant 9,738,688 - Caulfield , et al. August 22, 2	2017-08-22
Immunogens of HIV-1 broadly neutralizing antibodies, methods of generation and uses thereof Grant 9,707,290 - Schief , et al. July 18, 2	2017-07-18
Novel Vesicular Stomatitis Virus And Virus Rescue System App 20170198305 - Parks; Christopher L. ; et al.	2017-07-13
Replication-competent Vsv-hiv Env Vaccines App 20170095551 - Parks; Christopher L. ; et al.	2017-04-06
Recombinant viral vectors Grant 9,610,346 - Rabinovich , et al. April 4, 2	2017-04-04
Soluble Hiv-1 Envelope Glycoprotein Trimers App 20170035877 - Wyatt; Richard ; et al.	2017-02-09
Methods for identifying broadly neutralizing antibodies utilizing recombinant HIV-1 envelope glycoproteins comprising stabilizing mutations Grant 9,562,078 - Hoffenberg , et al. February 7, 2	2017-02-07
Broadly neutralizing human immunodeficiency virus type 1 (HIV-1) GP120-specific monoclonal antibody Grant 9,464,131 - Chan-Hui , et al. October 11, 2	2016-10-11
Novel Hiv -1 Broadly Neutralizing Antibodies App 20160289305 - Mascola; John ; et al.	2016-10-06
Soluble Hiv-1 Envelope Glycoprotein Trimers App 20160279230 - Sharma; Shailendra Kumar ; et al.	2016-09-29
Soluble Hiv-1 Envelope Glycoprotein Trimers App 20160272948 - Dubrovskaya; Viktoriya ; et al.	2016-09-22
Broadly Neutralizing Human Immunodeficiency Virus Type 1 (hiv-1) Gp120-specific Monoclonal Antibody App 20160264649 - Chan-Hui; Po-Ying ; et al.	2016-09-15
Methods To Improve Vector Expression And Genetic Stability App 20160222392 - Parks; Christopher L. ; et al.	2016-08-04
Viral particles derived from an enveloped virus Grant 9,402,894 - King , et al. August 2, 2	2016-08-02
Novel Cdv Vector Membrane Glycoprotein Variants App 20160201087 - Zhang; Xinsheng ; et al.	2016-07-14
HIV-1 broadly neutralizing antibodies Grant 9,382,311 - Mascola , et al. July 5, 2	2016-07-05
Engineered Outer Domain (eod) Of Hiv Gp120 And Mutants Thereof App 20160185825 - Huang; Po-Ssu ; et al.	2016-06-30
Recombinant Viral Vectors App 20160152666 - PARKS; Christopher L. ; et al.	2016-06-02
Methods to improve vector expression and genetic stability Grant 9,347,065 - Parks , et al. May 24, 2	2016-05-24
Mammalian Protein Co-recognition By Broadly Neutralizing Antibodies As Modified Immunogens For Re-elicitation App 20160033532 - Wyatt; Richard ; et al.	2016-02-04
Broadly Neutralizing Antibody And Uses Thereof App 20150361160 - Burton; Dennis R. ; et al.	2015-12-17
Immunogens Of Hiv-1 Broadly Neutralizing Antibodies, Methods Of Generation And Uses Thereof App 20150238594 - Schief; William R. ; et al.	2015-08-27
Monoclonal Antibodies Directed Against Trimeric Forms Of The Hiv-1 Envelope Glycoprotein With Broad And Potent Neutralizing Activity App 20150218257 - Chan-Hui; Po-Ying ; et al.	2015-08-06
Monoclonal antibodies directed against trimeric forms of the HIV-1 envelope glycoprotein with broad and potent neutralizing activity Grant 9,051,362 - Chan-Hui , et al. June 9, 2	2015-06-09
Methods Of Identifying Novel Hiv-1 Immunogens App 20150065381 - HOFFENBERG; SIMON ; et al.	2015-03-05
Engineered Outer Domain (eod) Of Hiv Gp120 And Mutants Thereof App 20140322269 - Huang; Po-Ssu ; et al.	2014-10-30
Novel Hiv-1 Envelope Glycoprotein App 20140212458 - Caulfield; Michael ; et al.	2014-07-31
HIV-1 clade a consensus sequences, antigens, and transgenes Grant 8,735,542 - Gupta , et al. May 27, 2	2014-05-27
Hiv-1 Envelope Glycoprotein App 20140037681 - HOFFENBERG; Simon ; et al.	2014-02-06
HIV-1 envelope glycoprotein Grant 8,586,056 - Phogat , et al. November 19, 2	2013-11-19
Recombinant Viral Vectors App 20130266611 - Rabinovich; Svetlana ; et al.	2013-10-10
Methods To Improve Vector Expression And Genetic Stability App 20130266989 - Parks; Christopher L. ; et al.	2013-10-10
Novel Hiv -1 Broadly Neutralizing Antibodies App 20130251726 - Mascola; John ; et al.	2013-09-26
Immunoselection Of Recombinant Vesicular Stomatitis Virus Expressing Hiv-1 Proteins By Broadly Neutralizing Antibodies App 20130189754 - Parks; Christopher L. ; et al.	2013-07-25
Viral Particles Derived From An Enveloped Virus App 20130129778 - King; C. R. ; et al.	2013-05-23
Novel Vesicular Stomatitis Virus And Virus Rescue System App 20130095556 - PARKS; Christopher L. ; et al.	2013-04-18
HIV-1 Clade A consensus sequences, antigens, and transgenes Grant 8,119,144 - Gupta , et al. February 21, 2	2012-02-21
Method of inducing high-titer neutralizing antibody responses in a host by administering immune complexes comprising anti-HIV-1 Env antibodies and the HIV-1 Env Grant 8,105,600 - Koff , et al. January 31, 2	2012-01-31
Chimeric human immunodeficiency virus (HIV) immunogens comprising GAG P24-P17 fused to multiple cytotoxic T lymphocyte (CTL) epitopes Grant 7,993,651 - Hanke , et al. August 9, 2	2011-08-09
Antigen Antibody Complexes as HIV-1 Vaccines App 20090123485 - Koff; Wayne C. ; et al.	2009-05-14

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.